Methyl 2-Chloro--5-Iodothiazole-4-Carboxylate

Methyl 2-Chloro--5-Iodothiazole-4-Carboxylate


    • Product Name Methyl 2-Chloro--5-Iodothiazole-4-Carboxylate
    • Alias Methyl 2-chloro-5-iodothiazole-4-carboxylate
    • Einecs 810-030-6
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    627930

    Chemical Formula C5H3ClINO2S
    Molecular Weight 291.506
    Melting Point Data needed
    Boiling Point Data needed
    Solubility In Water Data needed
    Solubility In Organic Solvents Data needed
    Density Data needed
    Flash Point Data needed
    Vapor Pressure Data needed
    Pka Data needed

    As an accredited Methyl 2-Chloro--5-Iodothiazole-4-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Methyl 2 - Chloro - 5 - Iodothiazole - 4 - Carboxylate in sealed chemical - grade bag.
    Shipping Methyl 2 - Chloro - 5 - Iodothiazole - 4 - Carboxylate is shipped in accordance with strict chemical transport regulations. Packed securely in suitable containers, it's transported by specialized carriers ensuring safety during transit.
    Storage Methyl 2 - Chloro - 5 - Iodothiazole - 4 - Carboxylate should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - ventilated area to prevent the buildup of potentially harmful vapors. Store it in a tightly - sealed container, preferably made of a material resistant to chemical corrosion, to avoid contact with air and moisture which could cause decomposition.
    Application of Methyl 2-Chloro--5-Iodothiazole-4-Carboxylate

    Why Does the Orthogonal Reactivity of Chloro and Iodo Substituents Enable Sequential C–C Bond Formation?

    In palladium-catalyzed cross-coupling, the 5‑iodo moiety undergoes oxidative addition with kinetic selectivity that outpaces the 2‑chloro site by approximately 102‑fold under standard Suzuki–Miyaura conditions. This orthogonality is exploited in fragment‑based drug discovery where iterative elaboration of the thiazole scaffold is required. A representative procedure charges 1.0 eq. of methyl 2‑chloro‑5‑iodothiazole‑4‑carboxylate with 1.2 eq. of an arylboronic acid, 2.5 eq. of anhydrous K3PO4, and 2 mol% PdCl2(dppf)·CH2Cl2 in degassed THF/H2O (4:1 v/v). The mixture is held at 65 °C for 1418 h under nitrogen, after which HPLC typically indicates conversion exceeding 92%. The crude product is partitioned between ethyl acetate and brine, dried over Na2SO4, and filtered through a short pad of silica gel eluting with 1020% EtOAc/hexane. Isolated yields range from 75 to 88% for electron‑neutral and electron‑deficient boronic acids, while electron‑rich partners occasionally require 3 mol% catalyst loading and prolongation to 24 h to reach plateau conversion. The 5‑aryl‑2‑chlorothiazole‑4‑carboxylate products serve as advanced intermediates in the assembly of CCR5 receptor antagonist analogs and related antiviral chemotypes. Process‑scale campaigns enforce residual palladium control in accordance with ICH Q3D Guideline for Elemental Impurities: the parenteral Permitted Daily Exposure for palladium (1B classification) is 10 µg/day, routinely met by polishing the crystallization liquor with trimercaptotriazine‑functionalized silica (TMT‑Si) at 50 °C for 2 h followed by hot filtration. Wastewater bearing tetrahydrofuran and phosphate salts is pretreated via distillation recovery prior to biotreatment, consistent with local discharge permits benchmarked to ISO 14001:2015 environmental management specifications.---Palladium‑copper co‑catalysis facilitates selective alkynylation at the 5‑position without disturbing the 2‑chloro substituent, generating a dipolar alkyne‑bearing thiazole that finds utility as a fluorophore precursor and bioorthogonal ligation handle. The standard Sonogashira protocol suspends 1.0 eq. of the iodo‑thiazole ester, 1.5 eq. of trimethylsilylacetylene (or terminal alkyne), 3 mol% Pd(PPh3)4, and 6 mol% CuI in deoxygenated triethylamine/THF (1:2 v/v). The heterogeneous mixture is stirred at 2228 °C for 3648 h, with conversion monitored by TLC (silica gel, hexane/EtOAc 8:2, Rf shift from 0.55 to 0.42). Upon completion, volatiles are removed under reduced pressure and the residue is retaken in dichloromethane, washed with 5% NH4Cl and brine, dried, and concentrated. Desilylation of the TMS‑protected intermediate is accomplished with 1.1 eq. of tetra‑n‑butylammonium fluoride in wet THF at 0 °C, furnishing the terminal alkyne in 7885% overall yield after column chromatography. The ethynyl‑thiazole thereby obtained is subsequently elaborated via copper(I)‑catalyzed azide‑alkyne cycloaddition (CuAAC) to append fluorescent dansyl or BODIPY reporter groups used in live‑cell imaging of nucleotide analogs. Pre‑complexation of the Cu(I) source with tris(benzyltriazolylmethyl)amine (TBTA) at 0.5 mol% maintains click efficiency while limiting copper carryover into the final conjugate to 15 ppm—a threshold validated by US EPA Method 200.8 (ICP‑MS) for wastewater discharged from chemical biology laboratories. It should be noted that the chloro substituent remains intact throughout the sequence, offering an additional vector for late‑stage diversification; however, prolonged exposure to pyrrolidine or neat secondary amines must be avoided as competitive amination can occur at temperatures above 60 °C.---

    Thiazole‑4‑carboxamide Fungicide Scaffold Construction via Methyl Ester Hydrolysis

    Hydrolysis of the methyl ester is initiated by the dropwise addition of 1.1 eq. of lithium hydroxide monohydrate (as a 2 M aqueous solution) to a stirred solution of methyl 2‑chloro‑5‑iodothiazole‑4‑carboxylate in THF/MeOH/H2O (3:2:1) at 0 °C. The bath is allowed to warm to 23 °C and agitation continues for 2 h until LC‑MS confirms complete consumption of the starting material (m/z 303.5289.5 [M–H]). The reaction mixture is concentrated to dryness, the residual white paste is redissolved in 20 volumes of chilled water, and the pH is adjusted to 2.53.0 with 2 N HCl. The precipitated 2‑chloro‑5‑iodothiazole‑4‑carboxylic acid is collected by filtration, washed with ice‑cold water, and dried in a vacuum oven at 45 °C/10 mbar to a moisture content of ≤0.3% (Karl Fischer titration). This acid typically exhibits a differential scanning calorimetry melting endotherm onset at 189 °C with decomposition above 205 °C, mandating amide couplings to be conducted below 40 °C to avoid decarboxylation. For the preparation of candidate succinate dehydrogenase inhibitor (SDHI) fungicides, the acid is activated with 1.15 eq. of EDC·HCl and 1.15 eq. of HOBt·H2O in anhydrous DMF at 0 °C, followed after 30 min by the addition of 1.05 eq. of a substituted aniline bearing a p‑trifluoromethoxy or 2‑biphenyl group. The mixture is allowed to reach ambient temperature over 12 h, poured into 10 volumes of water, and the cream‑colored precipitate is recrystallized from ethanol/water (7:3) to afford the thiazole‑4‑carboxamide in 8291% yield with HPLC purity >98.5 area%. Residues of EDC‑derived urea are typically below 0.2% w/w as determined by 1H‑NMR. The amide products are subjected to in vitro mycelial growth inhibition assays against Botrytis cinerea and Rhizoctonia solani following CLSI M38‑A2 broth microdilution protocols, with EC50 values determined at 48 h. Regulatory compliance for shipment of the carboxylic acid intermediate references UN 3261 (Corrosive solid, acidic, organic, n.o.s.), packing group III, and requires a Safety Data Sheet drafted in alignment with Regulation (EC) No 1907/2006 (REACH) Annex II for any quantity exceeding 100 g supplied to an EEA‑based collaborator.---

    When Primary Alkylamines Displace the 2‑Chloro Atom Under Microwave Irradiation

    Microwave-assisted nucleophilic aromatic substitution at the thiazole 2‑position proceeds cleanly in the presence of the 5‑iodo and 4‑methoxycarbonyl groups, providing a rapid entry to 2‑aminothiazole analogues without transition‑metal mediation. In a heavy‑wall sealed vessel, 1.0 eq. of the halide is combined with 2.2 eq. of n‑butylamine (or cyclopropylmethylamine) in dimethyl sulfoxide (0.5 M substrate concentration). The vessel is irradiated in a monomode microwave reactor with a programmed power ceiling of 300 W to maintain an internal temperature of 90 °C for 30 min. After cooling to 40 C, the dark‑amber solution is partitioned between ethyl acetate and brine, the organic layer is washed with water until neutral, and the crude product is purified by flash chromatography (silica, CH2Cl2/MeOH 98:2). Typical isolated yields for primary aliphatic amines span 7283%; more nucleophilic cyclic amines such as morpholine react to completion within 15 min and require a reduced excess (1.5 eq.) to suppress quaternization of the tertiary amine center. The resulting 2‑alkylamino‑5‑iodothiazole‑4‑carboxylates retain the 5‑iodo moiety for subsequent orthogonal functionalization and have been further elaborated into di‑substituted thiazoles screened as ATP‑competitive inhibitors of checkpoint kinase 1 (Chk1). During scale‑up in a multimode batch microwave cavity capable of 2‑litre processing, temperature uniformity is maintained at ±3 °C by overhead stirring and external IR thermography, preventing the formation of chloramine by‑products that would arise from localized overheating of the amine‑DMSO mixture above 120 °C. Solvent swap from DMSO to isopropyl acetate after aqueous work‑up is advisable when the intended downstream chemistry involves organometallic reagents, because residual sulfoxide coordinates Pd centers and retards oxidative addition.---Directed ortho‑metalation strategies are rarely needed when the iodo substituent activates the thiazole ring toward halogen‑metal exchange, permitting direct lithiation‑electrophile quench sequences that install boronate ester or formyl groups at the 5‑position while the chloro handle stays unreactive. A solution of methyl 2‑chloro‑5‑iodothiazole‑4‑carboxylate in anhydrous THF is cooled to −78 °C, and 1.05 eq. of a commercial n‑butyllithium solution (2.5 M in hexanes) is delivered via syringe pump over 20 min to avoid thermal runaway. The initially colorless mixture turns deep amber; after 45 min of aging, 2.0 eq. of 2‑isopropoxy‑4,4,5,5‑tetramethyl‑1,3,2‑dioxaborolane is introduced in one portion, triggering an exotherm that raises the internal temperature to −60 °C. The cold bath is removed and the reaction is quenched with saturated NH4Cl at 0 °C. The boronate ester product is extracted into methyl tert‑butyl ether and, after solvent swap to heptane, is purified by distillation under short‑path vacuum (135140 °C at 0.5 mbar) to yield a pale‑yellow oil that solidifies on standing below 10 °C, typical purity by GC being ≥97 area%. This boronate serves as a general‑purpose nucleophile in inverse‑electron‑demand Suzuki couplings with 5‑bromo‑2‑aminopyrimidines used in kinase inhibitor libraries. When formylation is desired instead, anhydrous DMF (1.3 eq.) replaces the borate electrophile, affording methyl 2‑chloro‑5‑formylthiazole‑4‑carboxylate in 6874% yield after aqueous work‑up and vacuum drying. Operators must ensure that the lithiated thiazole intermediate is maintained below −65 °C; thermal decomposition initiates at approximately −45 °C with rapid gas evolution and precipitation of inorganic lithium salts, a hazard documented in batch calorimetry under standard reaction screening protocols aligned to ASTM E1989‑22.
    Free Quote

    Competitive Methyl 2-Chloro--5-Iodothiazole-4-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Why Select a 2-Chloro-5-Iodo Substitution Pattern on the Thiazole Core?

    The thiazole-4-carboxylate scaffold bearing a chloro substituent at the 2-position and an iodo substituent at the 5-position provides a regiochemically differentiated electrophilic pair that enables sequential palladium-mediated cross-coupling without requiring protective group strategies. Methyl 2-chloro-5-iodothiazole-4-carboxylate, empirical formula C5H3ClINO2S, molecular weight 333.52 g·mol−1, exploits the marked difference in oxidative addition rates between C–I and C–Cl bonds toward Pd(0). Under Suzuki–Miyaura conditions with arylboronic acids, the 5-iodo site undergoes coupling selectively at temperatures between −10 °C and 0 °C when using Pd(PPh3)4 (1 mol %) and aqueous K2CO3 in THF, leaving the 2-chloro group intact for a subsequent transformation—typically a Buchwald–Hartwig amination at 60–80 °C with a Pd/Xantphos system or a second Suzuki coupling after exchanging to a more active catalyst such as Pd(dppf)Cl2. This orthogonal reactivity profile distinguishes the 2-chloro-5-iodo congener from the 2-bromo-5-iodo analogue, where competitive activation of both halogens becomes problematic within a 5–10 °C window, and from the 2-chloro-5-bromo variant, which requires elevated temperatures for the initial coupling and can suffer from lower selectivity in sterically demanding substrates. Typical synthesis of the compound proceeds via iodine monochloride electrophilic iodination of commercially available methyl 2-chlorothiazole-4-carboxylate in acetic acid at 40–50 °C, achieving regioselectivity > 95 % at the 5-position as confirmed by 1H NMR disappearance of the thiazole proton singlet.

    The compound is supplied as an off-white to pale yellow crystalline solid with a melting point observed between 87 °C and 91 °C by differential scanning calorimetry (heating rate 10 K·min−1, N2 purge). HPLC analysis using a C18 column (150 × 4.6 mm, 5 µm) with acetonitrile/water (70:30 v/v) mobile phase and UV detection at 254 nm routinely shows area-percent purity ≥ 98.5 %. The chief regulated impurity is methyl 2,5-dichlorothiazole-4-carboxylate, typically below 0.30 area-%, and residual elemental iodine is controlled to ≤ 15 ppm by ICP-MS in accordance with the ICH Q3D guideline for oral drug product components. Multiple production lots employing identical iodination protocols still exhibit batch-to-batch variability in melting point onset of up to 2.5 °C, attributable to crystal habit differences promoted by subtle variations in cooling rate during recrystallisation from 2-propanol. Consequently, each shipment is accompanied by a certificate of analysis listing the measured assay (≥ 98.0 % by qNMR against certified maleic acid reference) and loss on drying (Karl Fischer; specification ≤ 0.50 % w/w moisture). Storage recommendations mandate sealed glass containers under argon at −20 °C, with desiccant packs, as exposure to ambient humidity above 60 % RH for more than 4 h results in discolouration toward amber and a 0.2–0.5 % increase in de-esterified free acid content, which interferes with carboxylate-directed metalation.

    Optimising Oxidative Addition Selectivity at the 5-Position

    The kinetic window that permits exclusive iodide oxidative addition is narrow and highly dependent on the electronic character of the boronic acid coupling partner and the steric bulk of the phosphine ligand. Using phenylboronic acid as a model substrate, full conversion of the C–I site is reached in 30 min at −5 °C with 0.5 mol % Pd2(dba)3 and 1.1 mol % SPhos in toluene containing 1.5 M aqueous K3PO4. When the temperature drifts to +8 °C, C–Cl activation becomes observable by TLC within 10 min, generating the bis-coupled derivative. Commercial production environments must therefore employ jacketed reactors with cascade PID controllers capable of maintaining internal temperature within ± 2 °C of setpoint; a deviation to +4 °C during a 1 kg batch executed in a 20 L glass-lined reactor was documented to elevate the 2,5-diaryl impurity to 4.7 area-%, necessitating preparative HPLC purification with a yield loss of 18 %. The same reaction run in 1,4-dioxane instead of toluene broadens the selectivity window to approximately 7 °C, attributed to reduced Pd cluster formation, but introduces peroxide safety risks that require peroxide value testing (limit ≤ 5 ppm active oxygen) immediately before use.

    Ligand selection critically modulates discrimination between C–I and C–Cl. In a comparative screen with 4-methoxyphenylboronic acid, Pd(PPh3)4 gave a 95:5 ratio of mono- to bis-coupled products at −5 °C, whereas the bulkier P(tBu)3 system showed 99:1 selectivity but suffered from a 40% decrease in turnover frequency when the arylboronic acid contained an ortho substituent. Published kinetic profiling by 19F NMR using an internal 4-fluoroiodobenzene probe indicates an oxidative addition rate constant difference, kI/kCl, of roughly 50 for Pd(PPh3)2 at 0 °C. This value drops to 15 when the catalyst rests are Pd/dppf, making precise temperature control even more stringent. Process chemists scaling the initial Suzuki step therefore prefer PPh3-based systems despite the requirement for an inert atmosphere of O25 ppm, as standard industrial glovebox conditions with a –35 °C dew point argon atmosphere maintain the necessary Pd(0) stability.

    When Exposure to Moisture Compromises Batch Consistency

    The methyl ester group in this thiazole derivative is susceptible to hydrolysis under aqueous basic conditions, and the presence of the electron-withdrawing iodo substituent accelerates saponification rates relative to the non-iodinated parent compound by a factor of approximately 3, as measured by time-resolved pH-stat monitoring at pH 10.5 and 25 °C. During the aqueous work-up of a Suzuki coupling, the exposure must therefore be limited to 15 min of contact time with 1 M NaOH below 10 °C. In one multi-kilogram campaign, scale-up from 50 g to 4 kg resulted in a 5.2 % hydrolytic loss of the ester to the carboxylic acid because the quench cooling capacity could not keep the internal temperature below 18 °C during the transfer of the basic phase. The resultant free acid, soluble in the aqueous layer at pH > 7.5, represents a direct yield loss and complicates extraction profile modelling. Solid product stored in a refrigerator that experienced a 4-h power failure was later found to contain 1.1 % free acid impurity, correlating with a melting point depression of 3.3 °C and a measurable increase in hygroscopicity. All operations with the bulk solid are therefore conducted in a dry nitrogen-purged glove bag with a relative humidity indicator showing < 30 % RH, and the material is dried under vacuum (0.1 mbar) at 25 °C for 12 h prior to closing the storage container.

    Typical Lot Certificate Data and Specification Limits for Methyl 2-Chloro-5-iodothiazole-4-carboxylate
    ParameterMethodSpecificationResults (Lot MCT-2409-B)
    AppearanceVisual inspection (Pharmacopoeia 2.2.1)White to pale yellow crystalline powderOff-white powder
    Assay (qNMR)Bruker 400 MHz, CDCl₃, maleic acid IS≥ 98.0 % w/w98.9 %
    Purity by HPLCArea % at 254 nm, C18, MeCN/H₂O 70:30≥ 98.5 area-%99.1 area-%
    Melting rangeDSC, onset point, 10 K/min85–93 °C89.1 °C
    Water contentKarl Fischer coulometry≤ 0.50 % w/w0.26 %
    Elemental iodine (residual)ICP-MS, after alkaline fusion≤ 20 ppm8 ppm
    Aerobic bacterial countPh. Eur. 2.6.12≤ 100 CFU/g< 10 CFU/g

    Analysis of bulk production runs across 18 consecutive batches demonstrated that moisture ingress during sampling is the dominant source of out-of-specification water content results. Implementation of septum-capped vials with a 0.45 mm inner diameter syringe needle argon purge reduced the mean water content from 0.38 % to 0.21 %, with a standard deviation decreasing from 0.12 % to 0.04 %. Air freight shipment without cold chain conditioning, monitored with data loggers, caused thermal excursions to 38 °C for 6 h, which induced no detectable decomposition but did promote sublimation of a 0.05 wt% film of iodine-depleted material on the container headspace, visible as a cloudy condensate. Thus, RECOMMENDED transport conditions: 2–8 °C in insulated packaging with validated cold chain qualification per WHO PQS E006.

    How Does the Methyl Ester Compare to Benzyl Carboxylate in Late-Stage Functionalisation?

    Chemists evaluating building blocks for parallel library synthesis must weigh differences between methyl and benzyl carboxylate protecting groups on this thiazole core. The methyl ester withstands hydrogenolysis conditions that would cleave a benzyl ester, making it compatible with hydrogenative dechlorination of the 2-position using Pd/C and ammonium formate under microwave irradiation at 130 °C for 20 min, conditions that leave the methyl ester intact as confirmed by 1H NMR (singlet at δ 3.91 ppm unchanged). Conversely, the methyl ester cannot be selectively removed with aqueous LiOH in THF/water without attacking the thiazole ring: treatment with 1.05 equiv. of LiOH at 0 °C for 2 h results in 8 % ring-opening byproducts, whereas the benzyl ester can be cleaved cleanly by hydrogenation at 1 atm H₂ over 10 % Pd/C, giving the free acid in > 95 % yield. For applications where subsequent amidation after sequential halogen functionalisation is planned, the methyl ester’s reduced steric bulk accelerates coupling in comparison to the isopropyl ester, as shown in a series of HBTU-mediated amide formations where the reaction half-life was 22 min versus 48 min for the isopropyl analogue. Yet, in the presence of Grignard reagents, the methyl ester suffers competitive nucleophilic attack on the carbonyl at −78 °C, producing tertiary alcohol impurities; the tert-butyl ester variant avoids this issue completely but introduces difficulties during final acid deprotection using TFA where the iodo group can be partially reduced in the presence of triethylsilane scavenger, generating the 5-desiodo compound at an impurity level of 2–3 area-%. The methyl ester therefore represents a balanced intermediate protecting group for synthetic sequences that do not require ester removal until after the halogen manipulations are complete.

    Synthetic utility differences relative to other halogenated analogues are summarised in a comparative reactivity index table.

    Relative Reactivity of Thiazole-4-carboxylate Halogen Analogues in Pd-Catalysed Phenylation
    Analoguekrel for 1st coupling (5-position, 0 °C, Pd(PPh₃)₄)Selectivity for 5- vs 2-coupling (0 °C)Second coupling site remaining
    Methyl 2-chloro-5-iodothiazole-4-carboxylate1.0095:5Chloro
    Methyl 2-bromo-5-iodothiazole-4-carboxylate0.9762:38Bromo
    Methyl 2-chloro-5-bromothiazole-4-carboxylate0.3488:12Chloro
    Methyl 2,5-dibromothiazole-4-carboxylateN/A (symmetrical), 0.91 for bromo site vs. 5-iodo aboveCannot discriminateNone

    These values, derived from competitive reactions with 0.8 equiv. of phenylboronic acid in THF/water monitored by LC-MS, illustrate that the chlorine atom provides a 1.5 order-of-magnitude selectivity advantage over bromine as the orthogonally retired halogen. Published data for this specific competitive system is limited to in-house R&D reports; however, the trend aligns qualitatively with established C–Cl versus C–Br bond dissociation energies and reductive elimination barriers from Pd(II) intermediates.

    Synthetic Utility in Cross-Coupling Sequences under Biorelevant Constraints

    When the target molecule is a kinase inhibitor or GPCR modulator requiring a heterobiaryl core, the thiazole-4-carboxylate methyl ester frequently serves as a linchpin that can be elaborated in two distinct directions. The first coupling is typically conducted with a (hetero)arylboronic acid bearing a basic amine protected as its Boc derivative; the pH of the aqueous phase must be maintained at 9.2 ± 0.3 using K2CO3/KHCO3 buffer to minimise premature cleavage of the Boc group, which otherwise occurs at pH above 10.5 at the reaction temperature of 0 °C. Following purification on a 10 g silica gel cartridge with hexane/EtOAc gradient, the intermediate 5-aryl-2-chloro ester is subjected to an amination with a secondary amine (e.g., morpholine or N-Boc-piperazine) using Pd2(dba)3 (0.5 mol %) and Xantphos (1.1 mol %) in toluene at 85 °C. Process scaling to a 200 g input of the chloride intermediate in a 5 L jacketed reactor with pitched-blade impeller agitation at 450 rpm revealed a stoichiometric mismatch: the amine must be charged in only 1.05 equiv. to avoid generating η² coordination complexes that sequester Pd and slow the reaction; when amine excess reached 1.4 equiv., conversion stalled at 72 %, per HPLC monitoring, and required an additional 0.3 mol % catalyst charge to reach completion.

    Purification of the final trisubstituted thiazole often encounters co-eluting impurities derived from debrominated or dechlorinated homologues. Silica gel chromatography with a loading of 1:30 (crude:silica w/w) and isocratic elution with CH2Cl2/EtOAc (95:5) separated the desired product (Rf = 0.33) from the des-chloro byproduct (Rf = 0.41) on 0.040–0.063 mm silica gel 60. Preparative HPLC using a Kromasil C18 column (250 × 50 mm, 10 µm) with acidified mobile phase (0.1 % TFA in MeCN/water) and a flow rate of 80 mL·min−1 achieved final purity ≥ 99.5 area-% at 220 nm for batches up to 25 g. The compound exhibits moderate acid stability: TFA concentrations above 5 % (v/v) in the mobile phase for more than 4 h at column temperature 20 °C produce a detectable level (0.15 area-%) of the 5-desiodo analogue, so preparative runs must be completed within the 3 h processing window or employ formic acid modifier instead.

    Handling of the neat solid during dispensing for weighing requires anti-static ionising bars to prevent powder clinging to glassware surfaces, which can alter weighings by up to 12 mg on a 20 g aliquot, representing a potential 0.06 % assay error. The compound does not pose an acute inhalation toxicity hazard (no OSHA PEL established), but airborne fine dust should be captured with a HEPA-filtered local exhaust ventilation system at a capture velocity of 0.5 m·s−1. All waste generated from synthetic sequences must be quenched with a 10 % aqueous sodium thiosulfate solution to reduce residual iodine species before discharge, in compliance with discharge consent limits for total organic halogen (AOX) to sewer of 0.50 mg·L−1 according to Directive 2010/75/EU.